Evergreen Capital Management’s Idexx Laboratories IDXX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$713K Buy
1,355
+740
+120% +$415K 0.01% 699
2026
Q1
$346K Sell
615
-75
-11% -$48.1K 0.01% 1017
2025
Q4
$467K Buy
690
+107
+18% +$72.9K 0.01% 786
2025
Q3
$372K Buy
583
+186
+47% +$113K 0.01% 819
2025
Q2
$213K Buy
+397
New +$190K 0.01% 1001

Other funds holding IDXX

Evergreen Capital Management's IDXX Position: Q2 2026 in Review

Evergreen Capital Management increased its Idexx Laboratories (IDXX) stake by 120% in Q2 2026, buying an estimated $415K and bringing the position to 1,355 shares worth $713K. The position accounts for 0.01% of the portfolio, ranked #699.

Evergreen Capital Management first reported a position in IDXX in Q2 2025 and has held it in 5 quarters since. 1,296 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

  • Evergreen Capital Management held 1,355 shares of Idexx Laboratories worth $713K as of Q2 2026.
  • Evergreen Capital Management bought 740 Idexx Laboratories shares in Q2 2026, an estimated $415K.
  • Idexx Laboratories made up 0.01% of Evergreen Capital Management's portfolio in Q2 2026, its #699 holding.
  • Evergreen Capital Management first reported a position in Idexx Laboratories in Q2 2025 and has held it in 5 quarters since.
  • 1,296 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on Evergreen Capital Management's 13F filing for Q2 2026, filed 23 Jul 2026.